Meeting Report
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

https://doi.org/10.1111/ajt.12590Get rights and content
Under a Creative Commons license
open archive

The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19–23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The meeting was highlighted by the presentation of the findings of several working groups formed at the 2009 and 2011 Banff meetings to: (1) establish consensus criteria for diagnosing antibody-mediated rejection (ABMR) in the presence and absence of detectable C4d deposition; (2) develop consensus definitions and thresholds for glomerulitis (g score) and chronic glomerulopathy (cg score), associated with improved inter-observer agreement and correlation with clinical, molecular and serological data; (3) determine whether isolated lesions of intimal arteritis (“isolated v”) represent acute rejection similar to intimal arteritis in the presence of tubulointerstitial inflammation; (4) compare different methodologies for evaluating interstitial fibrosis and for performing/evaluating implantation biopsies of renal allografts with regard to reproducibility and prediction of subsequent graft function; and (5) define clinically and prognostically significant morphologic criteria for subclassifying polyoma virus nephropathy. The key outcome of the 2013 conference is defining criteria for diagnosis of C4d-negative ABMR and respective modification of the Banff classification. In addition, three new Banff Working Groups were initiated.

Key words:

Acute allograft rejection
antibody-mediated rejection
Banff schema
cardiac allograft
chronic allograft rejection
complement C4d
composite tissue allograft
donor-specific antibodies
liver allograft
lung transplantation
pancreas allograft
renal transplantation
transplant biopsy
transplant glomerulopathy
transplant pathology

Abbreviations

ABMR
antibody-mediated rejection
ADCC
antibody-dependent cellular cytotoxicity
BIFQUIT
Banff initiative for quality assurance in transplantation
BWG
Banff Working Group
CAV
cardiac allograft vasculopathy
CD
cluster of differentiation
DeKAF
long-term deterioration of kidney allograft function
DSAs
donor-specific antibodies
DSAST
donor-specific antibody-selective gene transcript
EM
electron microscopy
ENDAT
endothelial activation and injury transcript
FOXP3
forkhead box P3
GBM
glomerular basement membrane
HLA
human leukocyte antigen (major histocompatibility complex)
IF
immunofluorescence
IF/TA
interstitial fibrosis and tubular atrophy
IgG
immunoglobulin G
IL
interleukin
IP
immunoperoxidase
ISHLT
International Society for Heart & Lung Transplantation
KOL
key opinion leader
MVI
microvascular injury
NKOL
new key opinion leader
pAMR
pathologic antibody-mediated rejection (heart allografts)
PAS
periodic acid-Schiff
TCMR
T cell–mediated rejection
TG
transplant glomerulopathy
VCA
vascularized composite allograft

Cited by (0)